Shanghai Fosun Pharmaceutical Group Co. scaled back its proposed purchase of control in Indian drugmaker Gland Pharma Ltd. to a level that would ...
Read more: China's Fosun scales back bid for India's Gland Pharma to $1.1 billion to avoid veto from CCEA